This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.
Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R)
Written by
accesswire
BOSTON, MA / ACCESS Newswire / July 31, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. (“Radius” or the “Company”), a specialty biopharmaceutical company focused on bone health and related areas, announced today that the U.S. District Court for the District of Massachusetts has ruled in favor of Radius and co-plaintiff Ipsen Pharma S.A.S. (“Ipsen”) in a patent infringement suit against Orbicular Pharmaceutical Technologies Private Ltd. (“Orbicular”) for their proposed generic for TYMLOS® (abaloparatide) for osteoporosis. Radius and Ipsen prevailed, and the court upheld the validity of all five TYMLOS® patents asserted, in which the latest to expire will remain in effect through April 30, 2038.
The suit was brought by Radius and Ipsen in September 2022 alleging patent infringement by Orbicular in their attempt to seek FDA approval to market a generic abaloparatide product. Radius asserted that Orbicular’s proposed generic product would infringe five patents held by Radius.
The favorable ruling reinforces the strength of the TYMLOS® patent portfolio and represents an important win for Radius.
About Radius:
Radius is a global biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. Radius’ lead product, TYMLOS® (abaloparatide) injection, a parathyroid hormone related peptide, is approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women and men with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. Abaloparatide is supplied as a single-patient multi-use prefilled pen designed to subcutaneously administer 80 micrograms per dose over a 30-day period. For additional information, please visit www.TYMLOS.com.
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media
As artificial intelligence tools increasingly shape how legal professionals are discovered and cited, a new legal publishing platform has launched with the goal of helping…
Waterlooville, Hampshire / Syndication Cloud / August 2, 2025 / MedFire Media division of Logjam Solutions Limited Key Takeaways: A strong digital presence is critical…
T.D.E. Wedding, well known for its event planning services, has announced an expansion aimed at meeting the needs of clients who want unique wedding experiences….
AI Engine That Curates Real-World Behavior to Power Personalized Intelligence Across Domains WESTPORT, CT / ACCESS Newswire / August 4, 2025 / Mobile Global Esports…
VIRGINIA BEACH, VA / ACCESS Newswire / August 4, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of…
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW…
New IRS enforcement initiative targets restaurants, salons, and other cash-heavy operations as audit risk rises in 2025 IRVINE, CA / ACCESS Newswire / August 4,…
-Company closes approximately $5.47 million in equity financing in 2Q/3Q25-TH104 potentially fills a critical National Security Need against Weaponized Fentanyl–TH023 may fulfill the promise of…
The funding accelerates the company’s mission to eliminate manual data operations by combining real-time monitoring, traceability and agentic AI to boost enterprise data reliability at…
HOUSTON, TX / ACCESS Newswire / August 4, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an independent upstream energy company…
When a business plateaus, most entrepreneurs respond by doing more—more content, more calls, more hours. But what if the solution isn’t in working harder, but…
BOSTON, MA / ACCESS Newswire / July 31, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. (“Radius” or the “Company”),…
Cross-platform synergy across NTTS TV, cable, social media, and NewsOut video press release amplification is delivering record-breaking visibility for public companies NEW YORK CITY, NEW…
Poole, Dorset / Syndication Cloud / July 31, 2025 / TechEd Publishers Key Takeaways Your smartphone can produce cinematic-quality videos when you apply the right…
The Newborn Care Solutions Agency is excited to share that it is expanding its services with a team of highly qualified professionals dedicated to supporting…
As San Diego County battles a growing surge in methamphetamine and fentanyl use, Sacred Journey Recovery in Vista, California, is offering a transformative solution for…
Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team NEW YORK CITY, NEW YORK / ACCESS Newswire /…
Exclusive Training Launches During National Compassionate Leadership Week at Regis College BAR HARBOR, ME / ACCESS Newswire / August 1, 2025 / As part of…
In an exclusive interview, the El Cajon tax preparer spotlights the human cost of disorganization and calls for better support for self-employed workers. EL CAJON,…
ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc….
The new cinematic trailer showcases Rust Mobile retaining the DNA of its PC predecessor, from cutthroat PvP to base raiding while offering the accessibility and…
In a heartfelt display of compassion and community service, Hooters of Panama City Beach joined hands with Salty Farm Ministry to support an event dedicated…
TORONTO, ON / ACCESS Newswire / August 1, 2025 / Eskay Mining Corp. (“Eskay” or the “Company”) (TSXV:ESK)(OTC PINK:ESKYF)(Frankfurt:KN7)(WKN:A0YDPM) is pleased to announce the offering…
SALT LAKE CITY, UT / ACCESS Newswire / July 31, 2025 / tZERO, a pioneer in digitally-native capital markets infrastructure, will launch the tZERO Chain,…
Flurry of new legislation including OBBBA, GENIUS Act, and aggressive tariff policies creates portfolio rebalancing opportunities amid market volatility NEW YORK, NY / ACCESS Newswire…
Free Educational Event Reveals How to Protect Retirement Assets from the Six Looming Financial Storms MENLO PARK, CA / ACCESS Newswire / July 31, 2025…
NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / IPOMarket.com, the digital media platform focused on high-impact pre-IPO and IPO coverage, announces…
